Learning Objectives:

1.  Identify when molecular testing should be considered in the evaluation of indeterminate thyroid nodules.

2.  Discuss differences in test methodology and summarize performance characteristics.

3.  Use genomic information in inform prognosis and management.

Session date: 
04/24/2023 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Sarah Mayson, M.D.